Targeting DNA topoisomerase II in cancer chemotherapy

John L Nitiss1

  • 1Molecular Pharmacology Department, St Jude Children's Research Hospital, Memphis, TN 38105, USA. john.nitiss@stjude.org

Nature Reviews. Cancer
|April 21, 2009
PubMed

Insights

Topoisomerase II (TOP2) is vital for genomic integrity and DNA replication. Interfering with TOP2 offers a promising strategy for developing new cancer chemotherapy treatments.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Topoisomerase II (TOP2) plays critical roles in DNA replication, transcription, and chromosome segregation.
  • Maintaining genomic integrity is essential, and TOP2 is a key enzyme involved.
  • Dysregulation of TOP2 can lead to genomic instability, making it a target for therapeutic intervention.

Purpose of the Study:

  • To explore the expanded biological roles of Topoisomerase II (TOP2) beyond its known functions.
  • To investigate how molecular tools can elucidate the mechanisms of TOP2-targeting drugs.
  • To highlight the potential for refined TOP2 targeting in cancer chemotherapy.

Main Methods:

  • Utilizing recent molecular studies to define TOP2's biological contexts.
  • Applying molecular tools to analyze drug interactions with TOP2.
  • Examining enzyme-mediated DNA damage as a result of TOP2 interference.

Main Results:

  • TOP2's functions are confirmed in DNA replication, transcription, and chromosome segregation.
  • Interference with TOP2 effectively generates enzyme-mediated DNA damage.
  • Molecular insights into TOP2 action are advancing drug development.

Conclusions:

  • Topoisomerase II (TOP2) is a crucial enzyme for genomic stability.
  • Targeting TOP2 presents a viable and effective strategy for cancer chemotherapy.
  • Further research promises refined and potent TOP2-based anticancer therapies.

Related Concept Videos

DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...